Evidence map›Paper›PMID 36932076›Full record

ArticleNature communications2023

Constitutively active Lyn kinase causes a cutaneous small vessel vasculitis and liver fibrosis syndrome.

Adriana A de Jesus, Guibin Chen, Dan Yang, Tomas Brdicka, Natasha M Ruth, David Bennin, Dita Cebecauerova, Hana Malcova, Helen Freeman, Neil Martin and 44 more

Open access · goldFull text read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 29 citations in OpenAlex.

  1. The Src-Family Kinases Hck, Fgr and Lyn Drive Immune Complex-Mediated Glomerulonephritis Through the Syk Tyrosine Kinase.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Role of Sam68 as an adaptor protein in inflammatory signaling.Cellular and molecular life sciences : CMLS · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

54 authors at 12 institutions in 4 countries.

Adriana A de Jesus *Translational Autoinflammatory Diseases Section (TADS), Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0001-8966-8362
Guibin Chen *National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Dan Yang *National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Tomas BrdickaLaboratory of Leukocyte Signaling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic.ORCID 0000-0002-1560-4398
Natasha M RuthMedical University of South Carolina, Charleston, SC, USA.
David BenninDepartments of Pediatrics and Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, WI, USA.
Dita CebecauerovaSecond Faculty of Medicine, Charles University/University Hospital Motol, Prague, Czech Republic.
Hana MalcovaSecond Faculty of Medicine, Charles University/University Hospital Motol, Prague, Czech Republic.
Helen FreemanRaigmore Hospital, Inverness, Scotland.ORCID 0000-0001-9181-1463
Neil MartinRoyal Hospital for Children, Glasgow, Scotland.
Karel SvojgrSecond Faculty of Medicine, Charles University/University Hospital Motol, Prague, Czech Republic.ORCID 0000-0003-1267-4072
Murray H PassoMedical University of South Carolina, Charleston, SC, USA.
Farzana BhuyanTranslational Autoinflammatory Diseases Section (TADS), Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Sara AlehashemiTranslational Autoinflammatory Diseases Section (TADS), Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Andre T RastegarTranslational Autoinflammatory Diseases Section (TADS), Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Katsiaryna UssTranslational Autoinflammatory Diseases Section (TADS), Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Lela KardavaLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Bernadette MarreroTranslational Autoinflammatory Diseases Section (TADS), Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Iris DuricLaboratory of Leukocyte Signaling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic.ORCID 0000-0002-5227-6522
Ebun OmoyinmiGreat Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Petra PeldovaSecond Faculty of Medicine, Charles University/University Hospital Motol, Prague, Czech Republic.
Chyi-Chia Richard LeeNational Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
David E KleinerNational Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Colleen M HadiganClinical Center, National Institutes of Health, Bethesda, MD, USA.
Stephen M HewittNational Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Stefania PittalugaNational Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0001-7688-1439
Carmelo Carmona-RiveraNational Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-7706-1464
Katherine R CalvoClinical Center, National Institutes of Health, Bethesda, MD, USA.
Nirali ShahNational Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-8474-9080
Miroslava BalascakovaSecond Faculty of Medicine, Charles University/University Hospital Motol, Prague, Czech Republic.
Danielle L FinkCollaborative Clinical Research Branch/Neutrophil Monitoring Laboratory, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USA.
Radana KotalovaSecond Faculty of Medicine, Charles University/University Hospital Motol, Prague, Czech Republic.
Zuzana ParackovaSecond Faculty of Medicine, Charles University/University Hospital Motol, Prague, Czech Republic.ORCID 0000-0002-2398-532X
Lucie PeterkovaSecond Faculty of Medicine, Charles University/University Hospital Motol, Prague, Czech Republic.ORCID 0000-0003-3653-8358
Daniela KuzilkovaSecond Faculty of Medicine, Charles University/University Hospital Motol, Prague, Czech Republic.ORCID 0000-0001-8086-9790
Vit CamprSecond Faculty of Medicine, Charles University/University Hospital Motol, Prague, Czech Republic.
Lucie SramkovaSecond Faculty of Medicine, Charles University/University Hospital Motol, Prague, Czech Republic.
Angelique BiancottoSanofi Oncology, Vitry, France.ORCID 0000-0003-2271-009X
Stephen R BrooksNational Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0001-5592-5332
Cameron ManesYale University, New Haven, CT, USA.
Eric MeffreYale University, New Haven, CT, USA.ORCID 0000-0003-4326-0171
Rebecca L HarperNational Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0003-1465-7372
Hyesun KuehnClinical Center, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-2154-3966
Mariana J KaplanNational Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0003-2968-0815
Paul BroganGreat Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Sergio D RosenzweigClinical Center, National Institutes of Health, Bethesda, MD, USA.
Melinda MerchantAstraZeneca Research Based Biopharmaceutical Company, Waltham, MA, USA.
Zuoming DengNational Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.
Anna HuttenlocherDepartments of Pediatrics and Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, WI, USA.
Susan L MoirLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-0163-6911
Douglas B KuhnsCollaborative Clinical Research Branch/Neutrophil Monitoring Laboratory, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USA.ORCID 0000-0002-9971-0760
Manfred Boehm *National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Karolina Skvarova Kramarzova *Second Faculty of Medicine, Charles University/University Hospital Motol, Prague, Czech Republic.ORCID 0000-0003-4860-7453
Raphaela Goldbach-Mansky *Translational Autoinflammatory Diseases Section (TADS), Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. goldbacr@mail.nih.gov.ORCID 0000-0001-7865-5769
National Institutes of Health · USCharles University · CZNational Institutes of Health Clinical Center · USCzech Academy of Sciences, Institute of Molecular Genetics · CZGreat Ormond Street Hospital for Children NHS Foundation Trust · GBMedical University of South Carolina · USUniversity of Wisconsin–Madison · USYale University · USAstraZeneca (United States) · USRaigmore Hospital · GBRoyal Hospital for Children · GBSanofi (France) · FR

Funding

Systemic AutoimmunityZIAAR041199 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI KAPLAN, MARIANA · 2014 to 2025
$32.5M
Role of B Lymphocytes In HIV Infection And PathogenesisZIAAI000825 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MOIR, SUSAN · 2009 to 2025
$24.5M
Vascular remodeling in patients with rare genetic disordersZIAHL006077 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI BOEHM, MANFRED · 2010 to 2025
$22.9M
Pathogenesis, and Outcome of Autoinflammatory Diseases, NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Stills-like Diseases, and other Undifferentiated Autoinflammatory DiseasesZIAAI001220 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI GOLDBACH-MANSKY, RAPHAELA · 2017 to 2025
$22.3M
Experimental Pathology Laboratory (EPL)ZICBC011638 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HEWITT, STEPHEN · 2015 to 2025
$16.6M
iPS-technology and patient specific disease modelsZIAHL006079 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI BOEHM, MANFRED · 2010 to 2025
$14.4M
Postmortem PathologyZICBC010685 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KLEINER, DAVID ERWIN · 2009 to 2025
$14.3M
Applying Bioinformatics to Research in Immune, Muscle, and Bone DiseasesZICAR041173 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI SUN, HONG-WEI · 2021 to 2025
$10.3M
6 · The paper itself

Abstract

Neutrophilic inflammation is a hallmark of many monogenic autoinflammatory diseases; pathomechanisms that regulate extravasation of damaging immune cells into surrounding tissues are poorly understood. Here we identified three unrelated boys with perinatal-onset of neutrophilic cutaneous small vessel vasculitis and systemic inflammation. Two patients developed liver fibrosis in their first year of life. Next-generation sequencing identified two de novo truncating variants in the Src-family tyrosine kinase, LYN, p.Y508*, p.Q507* and a de novo missense variant, p.Y508F, that result in constitutive activation of Lyn kinase. Functional studies revealed increased expression of ICAM-1 on induced patient-derived endothelial cells (iECs) and of β2-integrins on patient neutrophils that increase neutrophil adhesion and vascular transendothelial migration (TEM). Treatment with TNF inhibition improved systemic inflammation; and liver fibrosis resolved on treatment with the Src kinase inhibitor dasatinib. Our findings reveal a critical role for Lyn kinase in modulating inflammatory signals, regulating microvascular permeability and neutrophil recruitment, and in promoting hepatic fibrosis.

Indexed as

Endothelial Cellssrc-Family KinasesVasculitisDasatinibHumansInflammationNeutrophilsPhosphorylationDasatiniblyn protein-tyrosine kinasesrc-Family Kinases

Identifiers

PMID36932076
PMCPMC10022554
OpenAlexW4327715915

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read55
identifiers read1
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.